Results 211 to 220 of about 102,809 (306)

Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real‐world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World)

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 11, Page 6691-6704, November 2025.
Abstract Aims In this first interim analysis of the SCORE study, we investigated the risk of major adverse cardiovascular events (MACE) among individuals with atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity but without diabetes who initiated semaglutide 2.4 mg in real‐world settings.
Kim G. Smolderen   +10 more
wiley   +1 more source

The impact of the COVID‐19 pandemic on longitudinal trends of surgical mortality and inpatient quality of care in Ontario, Canada

open access: yesJournal of Advanced Nursing, Volume 81, Issue 11, Page 7556-7570, November 2025.
Abstract Aims Previous studies have shown the COVID‐19 pandemic was associated with reductions in volume across a spectrum of non‐SARS‐CoV‐2 hospitalizations. In the present study, we examine the impact of the pandemic on patient safety and quality of care. Design This is a retrospective population‐based study of discharge abstracts. Methods We applied
Steven Habbous   +4 more
wiley   +1 more source

Long-Term Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery: Comparison of Quinidine, Verapimil, and Amiodarone in Maintaining Sinus Rhythm

open access: gold, 1996
Ahmet Turan Yılmaz   +5 more
openalex   +1 more source

Hospital Cost of Complications Associated With Coronary Artery Bypass Graft Surgery

open access: hybrid, 1997
Ruth Hall   +3 more
openalex   +1 more source

Histidine‐Containing Dipeptides in Obesity and Cardiometabolic Health: A Systematic Scoping Review

open access: yesObesity Reviews, Volume 26, Issue 11, November 2025.
ABSTRACT Background Histidine‐containing dipeptides (HCDs) have been reported to have anti‐inflammatory and antidiabetic properties. Yet, no previous reviews have examined the impact of HCDs on Type 2 diabetes (T2D) risk factors (e.g., obesity) and progression (e.g., microvascular and macrovascular complications).
Saeede Saadati   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy